Vimarsana
Biggest News Aggregation in the World

Page 6 - Cm Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Life Sciences Today - Breaking & Trending Today

Zacks Investment Research Downgrades Sema4 (NASDAQ:SMFR) to Sell - Vimarsana News

Zacks Investment Research Downgrades Sema4 (NASDAQ:SMFR) to Sell

Sema4 (NASDAQ:SMFR – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal […]

EQRx (NASDAQ:EQRX) Shares Up 6.8% - Vimarsana News

EQRx (NASDAQ:EQRX) Shares Up 6.8%

EQRx Inc (NASDAQ:EQRX – Get Rating)’s share price shot up 6.8% during trading on Tuesday . The stock traded as high as $3.80 and last traded at $3.78. 2,577 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 1,494,552 shares. The stock had previously closed at $3.54. Separately, […]

Sema4 (NASDAQ:SMFR) Shares Down 6.2% - Vimarsana News

Sema4 (NASDAQ:SMFR) Shares Down 6.2%

Sema4 Holdings Corp (NASDAQ:SMFR – Get Rating)’s stock price traded down 6.2% during trading on Monday . The company traded as low as $2.81 and last traded at $2.89. 76,128 shares were traded during trading, a decline of 96% from the average session volume of 1,707,424 shares. The stock had previously closed at $3.08. Several […]

Sema4 (NASDAQ:SMFR) Announces Earnings Results - Vimarsana News

Sema4 (NASDAQ:SMFR) Announces Earnings Results

Sema4 (NASDAQ:SMFR – Get Rating) announced its earnings results on Monday. The company reported ($0.17) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.26) by $0.09, MarketWatch Earnings reports. Sema4 updated its FY 2022 guidance to EPS. NASDAQ SMFR traded up $0.05 during mid-day trading on Tuesday, hitting $2.70. The […]

Twist, Artisan Development Labs partner to discover cell therapies - Vimarsana News

Twist, Artisan Development Labs partner to discover cell therapies

Twist Bioscience has teamed up with Artisan Development Labs to discover new antibodies against five undisclosed targets.